Novo Nordisk thank you Abnehm-Medikament Wegovy kräftig

DJ Novo Nordisk waits thanks Abnehm-Medikament Wegovy kräftig

By Dominic Hakken

DOW JONES–Novo Nordisk has made a strong profit from Abnehm-Medikamenten. Therefore, if there is a problem, you need to take the next step. View the net profit from the analyst forecast analyses. The predictions for use and employee are one of the pharmaceutical solutions.

Der Umsatz von Wegovy kletterte een 79 Prozent auf 17.3 Billiarden dänische Kronen, omgerechnet 2.3 Billiarden Euro. Analysts have an opinion on Visible Alpha with 15.8 billion crowns. The value of the diabetes drugs amounts to 26 percent at 29.8 billion kroner, here analysts are with 30.5 million kroner an even greater share of the time. Der Gesamtumsatz wuchs um 21 Prozent auf 71 Billiarden Kronen. The net profit is worth 21 percent to 27.3 billion crowns.

The tensions for the konzern forecasts will be on the basis of the government’s watch states and the results of the analysis of the portfolio instruction will be determined. Der Umsatz soll dieses Jahr nun um 23 tot 27 Prozent statt 22 tot 28 Prozent steigen. The employee Gewinnwachstum is now a wechselkursreinigt from 21 to 27 Prozent statt 20 to 28 Prozent gesehen.

Contact the author: [email protected]

DJG/DJN/mgo/sha

(END) Dow Jones Newswires

November 6, 2024 02:51 ET (07:51 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.